Schrodinger raises $232M in IPO
Drug discovery software company Schrödinger raised $232 million in its IPO, which closed Monday. The company’s stock was trading at $27.22 on Tuesday.
Drug discovery software company Schrödinger raised $232 million in its IPO, which closed Monday. The company’s stock was trading at $27.22 on Tuesday.
Recursion's technology works by generating millions of cellular images and using AI-based software as a way to analyze the data set and screen potential therapeutic compounds against a variety of diseased cells.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.